{"disease":{"id":"coronavirus-disease-2019","name":"coronavirus disease 2019"},"drugs":{"marketed":[{"drug_id":"tocilizumab","indication_name":"Coronavirus Disease 2019 (COVID-19)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Roactemra","generic_name":"tocilizumab","company_name":"Roche","drug_phase":"marketed","molecular_target":"Interleukin-6 receptor","drug_class":"Interleukin-6 Receptor Antagonist [EPC]","quality_score":10,"revenue":null,"mechanism":"Roactemra works by blocking the interleukin-6 receptor, a protein that plays a key role in inflammation."}],"pipeline":[],"offLabel":[],"totalMarketed":1,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07072793","title":"A US Study to Look at Loss of Work and Healthcare Costs for People Affected With Mild-to-moderate COVID 19 Who Have High Chances of the Disease Becoming Severe","phase":"","overall_status":"COMPLETED","enrollment_count":131005,"lead_sponsor_name":"Pfizer","has_results":true},{"nct_id":"NCT04979208","title":"Impact of Changes in the Use of Care and Reorganization of the Healthcare System Linked to the Covid-19 Outbreak on the Quality of Care Pathways of Patients Suffering From Acute Myocardial Infarction and Stroke in Aquitaine (AVICOVID)","phase":"","overall_status":"COMPLETED","enrollment_count":9218,"lead_sponsor_name":"University Hospital, Bordeaux","has_results":false},{"nct_id":"NCT05097677","title":"Follow-up of Covid-19 Long Term Sequelae","phase":"","overall_status":"COMPLETED","enrollment_count":7599,"lead_sponsor_name":"Azienda Ospedaliera Universitaria Integrata Verona","has_results":false},{"nct_id":"NCT04327206","title":"BCG Vaccination to Protect Healthcare Workers Against COVID-19","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":6828,"lead_sponsor_name":"Murdoch Childrens Research Institute","has_results":false},{"nct_id":"NCT04375761","title":"COVID-19: Human Epidemiology and Response to SARS-CoV-2","phase":"","overall_status":"COMPLETED","enrollment_count":5599,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":true},{"nct_id":"NCT04545047","title":"Observational Study of Convalescent Plasma for Treatment of Veterans With COVID-19","phase":"","overall_status":"COMPLETED","enrollment_count":5044,"lead_sponsor_name":"VA Office of Research and Development","has_results":true},{"nct_id":"NCT05594147","title":"An Observational Study, Called ROCURS, to Learn About COVID-19 Related Outcomes in People With Cancer Who Are Treated With Tyrosine Kinase Inhibitors (TKIs) Including Regorafenib or Sorafenib","phase":"","overall_status":"COMPLETED","enrollment_count":4103,"lead_sponsor_name":"Bayer","has_results":false},{"nct_id":"NCT05722665","title":"Convolutional Neural Network Model to Detect Coronavirus Disease 2019 (COVID-19) Pneumonia in Chest Radiographs","phase":"","overall_status":"COMPLETED","enrollment_count":3599,"lead_sponsor_name":"Fundacion Clinica Valle del Lili","has_results":false},{"nct_id":"NCT06821061","title":"A Study to Learn About How the Flu and COVID-19 Vaccines Act in Healthy People","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":2650,"lead_sponsor_name":"BioNTech SE","has_results":false},{"nct_id":"NCT05534074","title":"University Hospital of Ioannina COVID-19 (Coronavirus Disease 2019) Registry","phase":"","overall_status":"UNKNOWN","enrollment_count":2500,"lead_sponsor_name":"University Hospital, Ioannina","has_results":false},{"nct_id":"NCT05330832","title":"Covid-19 Associated Coagulopathy Predicted by Thrombodynamic Markers (CoViTro-I)","phase":"","overall_status":"UNKNOWN","enrollment_count":2200,"lead_sponsor_name":"Federal Research Institute of Pediatric Hematology, Oncology and Immunology","has_results":false},{"nct_id":"NCT05787431","title":"Levels of Physical Activity After SARS-CoV-2 Infection in Pre-illness Vaccinated and Unvaccinated Greek Adults.","phase":"","overall_status":"UNKNOWN","enrollment_count":2000,"lead_sponsor_name":"Emmanouil D. Zacharakis","has_results":false},{"nct_id":"NCT04443712","title":"Screening for Patients Admitted to Ain-Shams University Hospitals for SARS-COV-2 (COVID19)","phase":"","overall_status":"UNKNOWN","enrollment_count":1900,"lead_sponsor_name":"Samia Girgis","has_results":false},{"nct_id":"NCT04508023","title":"A Study of Rivaroxaban to Reduce the Risk of Major Venous and Arterial Thrombotic Events, Hospitalization and Death in Medically Ill Outpatients With Acute, Symptomatic Coronavirus Disease 2019 (COVID-19) Infection","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":1284,"lead_sponsor_name":"Janssen Research & Development, LLC","has_results":true},{"nct_id":"NCT04378777","title":"Immunophenotyping Assessment in a COVID-19 Cohort","phase":"","overall_status":"COMPLETED","enrollment_count":1227,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":false},{"nct_id":"NCT05094687","title":"Cutaneous Manifestations of Coronavirus Disease 2019(COVID-19).","phase":"","overall_status":"COMPLETED","enrollment_count":1206,"lead_sponsor_name":"Jinnah Postgraduate Medical Centre","has_results":false},{"nct_id":"NCT07089680","title":"A Study to Learn About the Study Medicine Paxlovid (Nirmatrelvir + Ritonavir) in Adults Aged 60 and Older Living in Korean Long-term Care Hospitals Who Have COVID-19","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":1200,"lead_sponsor_name":"Pfizer","has_results":false},{"nct_id":"NCT04760990","title":"A Study to Assess the Potential Impact of Disease Modifying Therapies on COVID-19 Outcomes and the Antibody Response Following an Infection With SARS-CoV-2 in Patients With Multiple Sclerosis Within the Swiss Multiple Sclerosis Cohort.","phase":"","overall_status":"COMPLETED","enrollment_count":1181,"lead_sponsor_name":"University Hospital, Basel, Switzerland","has_results":false},{"nct_id":"NCT06392451","title":"LIAISON NES Influenza (FLU) A/B, Respiratory Syncytial Virus (RSV), & Coronavirus Disease 2019 (COVID-19) in Symptomatic Patients in Australia","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":1000,"lead_sponsor_name":"DiaSorin Molecular LLC","has_results":false},{"nct_id":"NCT05160636","title":"A Study to Look at the Health Outcomes of Patients With COVID-19 and Influenza","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":999,"lead_sponsor_name":"Pfizer","has_results":false},{"nct_id":"NCT04944433","title":"Safety and Efficacy of the Coronavirus Disease 2019 Vaccine in Hemodialysis Patients","phase":"","overall_status":"COMPLETED","enrollment_count":950,"lead_sponsor_name":"Hospital Italiano de Buenos Aires","has_results":false},{"nct_id":"NCT04394117","title":"Controlled evaLuation of Angiotensin Receptor Blockers for COVID-19 respIraTorY Disease","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":787,"lead_sponsor_name":"The George Institute","has_results":false},{"nct_id":"NCT05364671","title":"Clinical Trial of Efficacy and Safety of Raphamin in the Treatment of Coronavirus Disease 2019 in Outpatients","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":771,"lead_sponsor_name":"Materia Medica Holding","has_results":true},{"nct_id":"NCT05492227","title":"SARS-CoV-2 Nucleic Acid Detection Kit Clinical Performance Study","phase":"","overall_status":"COMPLETED","enrollment_count":607,"lead_sponsor_name":"TransGen Biotech Co., LTD","has_results":false},{"nct_id":"NCT06189040","title":"Immunogenicity After COVID-19 Vaccines in Adapted Schedules","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":580,"lead_sponsor_name":"Universiteit Antwerpen","has_results":false},{"nct_id":"NCT05364268","title":"Evaluation of the AudibleHealth Dx AI/ML-Based Dx SaMD Using FCV-SDS in the Diagnosis of COVID-19 Illness: Clinical Validation","phase":"","overall_status":"COMPLETED","enrollment_count":514,"lead_sponsor_name":"AudibleHealth AI, Inc.","has_results":false},{"nct_id":"NCT05164744","title":"Cardiac Magnetic Resonance Tissue Characterization in COVID-19 Survivors","phase":"","overall_status":"RECRUITING","enrollment_count":510,"lead_sponsor_name":"Weill Medical College of Cornell University","has_results":false},{"nct_id":"NCT04347239","title":"Evaluate the Efficacy & Safety of Leronlimab in Patients With Severe or Critical COVID-19","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":484,"lead_sponsor_name":"CytoDyn, Inc.","has_results":true},{"nct_id":"NCT04724850","title":"Evolution of Coronavirus Disease 2019 (COVID-19) Patients in Extremadura","phase":"","overall_status":"COMPLETED","enrollment_count":440,"lead_sponsor_name":"Juan Fernando Masa Jiménez","has_results":false},{"nct_id":"NCT04497194","title":"Registry of COVID-19 Patients at AOUI Verona","phase":"","overall_status":"COMPLETED","enrollment_count":430,"lead_sponsor_name":"Azienda Ospedaliera Universitaria Integrata Verona","has_results":false},{"nct_id":"NCT05089045","title":"Immunogenicity and Safety Evaluation of Recombinant Novel Coronavirus Vaccine (CHO Cells) in Enhancing Immunity","phase":"NA","overall_status":"COMPLETED","enrollment_count":360,"lead_sponsor_name":"Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.","has_results":false},{"nct_id":"NCT05007080","title":"A Study to Evaluate Different Dose Levels of Ad26.COV2.S in Healthy Adolescents From 12 to 17 Years Inclusive","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":304,"lead_sponsor_name":"Janssen Vaccines & Prevention B.V.","has_results":true},{"nct_id":"NCT05128643","title":"Clinical Study on the Immune Program of Recombinant Novel Coronavirus（COVID-19) Vaccine (CHO Cell)","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":300,"lead_sponsor_name":"Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.","has_results":false},{"nct_id":"NCT04898166","title":"Association of Androgenetic Alopecia and Severity of Coronavirus Disease 2019 (COVID-19).","phase":"","overall_status":"COMPLETED","enrollment_count":300,"lead_sponsor_name":"Syeda Mahanum Ali","has_results":true},{"nct_id":"NCT04403932","title":"Increased Risk of Severe Coronavirus Disease 2019 in Patients With Vitamin D Deficiency","phase":"","overall_status":"COMPLETED","enrollment_count":300,"lead_sponsor_name":"Hospital San Carlos, Madrid","has_results":false},{"nct_id":"NCT05107375","title":"Clinical Study of Recombinant Novel Coronavirus（COVID-19） Vaccine (CHO Cell) Combined With Influenza Vaccine","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":299,"lead_sponsor_name":"Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.","has_results":false},{"nct_id":"NCT05184062","title":"A Study to Evaluate the Safety and Tolerability of AZD7442 in Chinese Adults","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":272,"lead_sponsor_name":"AstraZeneca","has_results":true},{"nct_id":"NCT05375760","title":"A Randomized, Open-label, Dose-ranging Study in Adults and Pediatric Individuals ≥ 12 Years of Age to Assess the Safety, Immunogenicity, Pharmacokinetics, and Pharmacodynamics of AZD7442, for Pre-exposure Prophylaxis of COVID-19","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":251,"lead_sponsor_name":"AstraZeneca","has_results":true},{"nct_id":"NCT04588363","title":"COVID-19: Pediatric Research Immune Network on SARS-CoV-2 and MIS-C","phase":"","overall_status":"COMPLETED","enrollment_count":244,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":false},{"nct_id":"NCT04401436","title":"COVID-19 Associated Lymphopenia Pathogenesis Study in Blood","phase":"","overall_status":"COMPLETED","enrollment_count":240,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":false},{"nct_id":"NCT04317040","title":"Efprezimod Alfa (CD24Fc, MK-7110) as a Non-antiviral Immunomodulator in COVID-19 Treatment (MK-7110-007)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":234,"lead_sponsor_name":"Oncoimmune, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)","has_results":true},{"nct_id":"NCT05897515","title":"LIAISON NES Influenza (FLU) A/B & Coronavirus Disease 2019 (COVID-19) Clinical Agreement in Australia","phase":"NA","overall_status":"COMPLETED","enrollment_count":233,"lead_sponsor_name":"DiaSorin Molecular LLC","has_results":false},{"nct_id":"NCT04894409","title":"Evaluation of Silver Nanoparticles for the Prevention of COVID-19","phase":"NA","overall_status":"COMPLETED","enrollment_count":231,"lead_sponsor_name":"Cluster de Bioeconomia de Baja California, A.C","has_results":false},{"nct_id":"NCT04742725","title":"A Study to Evaluate the Efficacy and Safety of Prothione™ Capsules for Mild to Moderate Coronavirus Disease 2019 (COVID-19)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":231,"lead_sponsor_name":"Prothione, LLC","has_results":false},{"nct_id":"NCT04388631","title":"Detection Rate of SARS-CoV-2 in Male Genitourinary System and Its Impact on Male Reproductive Health.","phase":"","overall_status":"UNKNOWN","enrollment_count":200,"lead_sponsor_name":"Tongji Hospital","has_results":false},{"nct_id":"NCT06305793","title":"RECOVER-AUTONOMIC: Platform Protocol, Appendix A (IVIG)","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":200,"lead_sponsor_name":"Kanecia Obie Zimmerman","has_results":false},{"nct_id":"NCT04673279","title":"Long-term COVID-19 Immune Response in a Vulnerable Neighbourhood in Argentina","phase":"","overall_status":"COMPLETED","enrollment_count":189,"lead_sponsor_name":"Hospital Italiano de Buenos Aires","has_results":false},{"nct_id":"NCT04988217","title":"Inhaled Interferon α2b for the Treatment of Coronavirus Disease 19 (COVID-19)","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":173,"lead_sponsor_name":"Pontificia Universidad Catolica de Chile","has_results":false},{"nct_id":"NCT04967781","title":"Autoimmunity Contributes to the Severe Progression of COVID-19","phase":"","overall_status":"COMPLETED","enrollment_count":162,"lead_sponsor_name":"Zhongnan Hospital","has_results":false},{"nct_id":"NCT05886829","title":"Chlorpheniramine Nasal Spray to Accelerate COVID-19 Clinical Recovery in an Outpatient Setting: ACCROS-III","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":157,"lead_sponsor_name":"Dr. Ferrer BioPharma","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}